Anita Dushyanth
Stock Analyst at Berenberg
(2.75)
# 1,940
Out of 4,945 analysts
4
Total ratings
75%
Success rate
15.74%
Average return
Main Sectors:
Stocks Rated by Anita Dushyanth
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| URGN UroGen Pharma | Initiates: Buy | $20 | $19.62 | +1.94% | 1 | Apr 27, 2022 | |
| SERA Sera Prognostics | Initiates: Buy | $13 | $2.24 | +480.36% | 1 | Apr 27, 2022 | |
| BTAI BioXcel Therapeutics | Initiates: Buy | $1,200 | $4.76 | +25,110.08% | 1 | Apr 9, 2021 | |
| PCRX Pacira BioSciences | Initiates: Buy | $93 | $24.94 | +272.89% | 1 | Apr 9, 2021 |
UroGen Pharma
Apr 27, 2022
Initiates: Buy
Price Target: $20
Current: $19.62
Upside: +1.94%
Sera Prognostics
Apr 27, 2022
Initiates: Buy
Price Target: $13
Current: $2.24
Upside: +480.36%
BioXcel Therapeutics
Apr 9, 2021
Initiates: Buy
Price Target: $1,200
Current: $4.76
Upside: +25,110.08%
Pacira BioSciences
Apr 9, 2021
Initiates: Buy
Price Target: $93
Current: $24.94
Upside: +272.89%